Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Use of a Basal Insulin and Glucobay For Reducing PPG to End Diabetes Progress

NCT01248481 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01248481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01248481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Use of a Basal Insulin and Glucobay For Reducing PPG to End Diabetes Progress
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
July 31, 2012
Enrollment
539 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus